These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Use of a new chemically modified intravenous IgG preparation in severe primary humoral immunodeficiency: clinical efficacy and attempts to individualize dosage. Schiff RI, Rudd C, Johnson R, Buckley RH. Clin Immunol Immunopathol; 1984 Apr; 31(1):13-23. PubMed ID: 6421523 [Abstract] [Full Text] [Related]
23. Anaphylaxis to IVIG. Williams SJ, Gupta S. Arch Immunol Ther Exp (Warsz); 2017 Feb; 65(1):11-19. PubMed ID: 27412077 [Abstract] [Full Text] [Related]
26. Immunoglobulin G (IgG) subclasses and human disease. Oxelius VA. Am J Med; 1984 Mar 30; 76(3A):7-18. PubMed ID: 6369977 [Abstract] [Full Text] [Related]
34. IgG subclasses in symptomatic IgA deficiency. Tezcan I, Ersoy F, Sanal O. Turk J Pediatr; 1992 Jan 30; 34(1):1-4. PubMed ID: 1509524 [Abstract] [Full Text] [Related]
35. Efficacy and safety of high-dose intravenous immune globulin therapy for antibody deficiency syndromes. Sorensen RU, Polmar SH. Am J Med; 1984 Mar 30; 76(3A):83-90. PubMed ID: 6424462 [Abstract] [Full Text] [Related]
39. Reconstitution of IgG Subclasses Following Immunoglobulin Administration in Adult Patients with Common Variable Immune Deficiency. Reeder D, Gupta S. Int Arch Allergy Immunol; 2021 Mar 30; 182(3):243-253. PubMed ID: 33053553 [Abstract] [Full Text] [Related]